Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection. (February 2023)
- Record Type:
- Journal Article
- Title:
- Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection. (February 2023)
- Main Title:
- Frequency of IRF5+ dendritic cells is associated with the TLR7-induced inflammatory cytokine response in SARS-CoV-2 infection
- Authors:
- Cords, Leon
Woost, Robin
Kummer, Silke
Brehm, Thomas T.
Kluge, Stefan
Schmiedel, Stefan
Jordan, Sabine
Lohse, Ansgar W.
Altfeld, Marcus
Addo, Marylyn M.
Schulze zur Wiesch, Julian
Beisel, Claudia - Abstract:
- Highlights: The peripheral blood dendritic cell compartment was significantly altered during SARS-CoV-2 infection. IRF5+ mDCs were significantly reduced in SARS-CoV-2 infected individuals compared with healthy donors. In response to TLR7 stimulation, mDCs of SARS-CoV-2 infected patients produced lower levels of IL-6. Our data provide insights into underlying mechanisms of TLR7-dependent immune dysfunction in COVID-19 and identify IRF5 as a potential immunomodulatory target in SARS-CoV-2 infection. Abstract: The SARS-CoV-2 infection leads to enhanced inflammation driven by innate immune responses. Upon TLR7 stimulation, dendritic cells (DC) mediate the production of inflammatory cytokines, and in particular of type I interferons (IFN). Especially in DCs, IRF5 is a key transcription factor that regulates pathogen-induced immune responses via activation of the MyD88-dependent TLR signaling pathway. In the current study, the frequencies of IRF5+ DCs and the association with innate cytokine responses in SARS-CoV-2 infected individuals with different disease courses were investigated. In addition to a decreased number of mDC and pDC subsets, we could show reduced relative IRF5+ frequencies in mDCs of SARS-CoV-2 infected individuals compared with healthy donors. Functionally, mDCs of COVID-19 patients produced lower levels of IL-6 in response to in vitro TLR7 stimulation. IRF5+ mDCs more frequently produced IL-6 and TNF-α compared to their IRF5− counterparts upon TLR7 ligation. TheHighlights: The peripheral blood dendritic cell compartment was significantly altered during SARS-CoV-2 infection. IRF5+ mDCs were significantly reduced in SARS-CoV-2 infected individuals compared with healthy donors. In response to TLR7 stimulation, mDCs of SARS-CoV-2 infected patients produced lower levels of IL-6. Our data provide insights into underlying mechanisms of TLR7-dependent immune dysfunction in COVID-19 and identify IRF5 as a potential immunomodulatory target in SARS-CoV-2 infection. Abstract: The SARS-CoV-2 infection leads to enhanced inflammation driven by innate immune responses. Upon TLR7 stimulation, dendritic cells (DC) mediate the production of inflammatory cytokines, and in particular of type I interferons (IFN). Especially in DCs, IRF5 is a key transcription factor that regulates pathogen-induced immune responses via activation of the MyD88-dependent TLR signaling pathway. In the current study, the frequencies of IRF5+ DCs and the association with innate cytokine responses in SARS-CoV-2 infected individuals with different disease courses were investigated. In addition to a decreased number of mDC and pDC subsets, we could show reduced relative IRF5+ frequencies in mDCs of SARS-CoV-2 infected individuals compared with healthy donors. Functionally, mDCs of COVID-19 patients produced lower levels of IL-6 in response to in vitro TLR7 stimulation. IRF5+ mDCs more frequently produced IL-6 and TNF-α compared to their IRF5− counterparts upon TLR7 ligation. The correlation of IRF5+ mDCs with the frequencies of IL-6 and TNF-α producing mDCs were indicators for a role of IRF5 in the regulation of cytokine responses in mDCs. In conclusion, our data provide further insights into the underlying mechanisms of TLR7-dependent immune dysfunction and identify IRF5 as a potential immunomodulatory target in SARS-CoV-2 infection. … (more)
- Is Part Of:
- Cytokine. Volume 162(2023)
- Journal:
- Cytokine
- Issue:
- Volume 162(2023)
- Issue Display:
- Volume 162, Issue 2023 (2023)
- Year:
- 2023
- Volume:
- 162
- Issue:
- 2023
- Issue Sort Value:
- 2023-0162-2023-0000
- Page Start:
- Page End:
- Publication Date:
- 2023-02
- Subjects:
- SARS-CoV-2 -- Dendritic cells -- Interferon regulatory factor 5 -- Toll-like receptor 7 -- Interferon-α -- Tumor necrosis factor-α -- Interleukin-6
COVID-19 Coronavirus Disease 2019 -- CRP C-reactive protein -- DC Dendritic cell -- ECMO Extracorporal membrane oxygenation -- HD Healthy donor -- ICU Intensive care unit -- IRF5 Interferon regulatory factor 5 -- IFN-α Interferon alpha -- IL-6 Interleukin 6 -- ILT-3 Immunoglobulin-like transcript 3 -- MFI Median fluorescence intensity -- mDC Myeloid Dendritic Cell -- MyD88 Myeloid differentiation primary response 88 -- PBMC Peripheral Blood Mononuclear Cell -- PCR Polymerase chain reaction -- pDC Plasmacytoid Dendritic Cell -- SARS-CoV-2 Severe acute respiratory syndrome coronavirus type 2 -- SNP single-nucleotide polymorphism -- TLR7 Toll-like receptor 7 -- TNF-α Tumor necrosis factor alpha
Cytokines -- Periodicals
571.844 - Journal URLs:
- http://www.sciencedirect.com/science/journal/10434666 ↗
http://www.elsevier.com/journals ↗ - DOI:
- 10.1016/j.cyto.2022.156109 ↗
- Languages:
- English
- ISSNs:
- 1043-4666
- Deposit Type:
- Legaldeposit
- View Content:
- Available online (eLD content is only available in our Reading Rooms) ↗
- Physical Locations:
- British Library DSC - 3506.778000
British Library DSC - BLDSS-3PM
British Library HMNTS - ELD Digital store - Ingest File:
- 24937.xml